GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EAFG | GSK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 71% | N/A |
| Stochastic ODDS (%) | 3 days ago 84% | 3 days ago 44% |
| Momentum ODDS (%) | 3 days ago 71% | 3 days ago 68% |
| MACD ODDS (%) | 3 days ago 64% | N/A |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 63% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 58% |
| Advances ODDS (%) | N/A | 3 days ago 61% |
| Declines ODDS (%) | 10 days ago 77% | 9 days ago 51% |
| BollingerBands ODDS (%) | 5 days ago 79% | 3 days ago 43% |
| Aroon ODDS (%) | N/A | 3 days ago 53% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RNRG | 33.60 | 0.18 | +0.53% |
| Global X Renewable Energy Producers ETF | |||
| SPSM | 48.02 | 0.19 | +0.40% |
| State Street SPDR Port S&P 600 Sm CpETF | |||
| KJUL | 31.91 | 0.01 | +0.04% |
| Innovator Russell 2000 Pwr Bffr ETF™ Jul | |||
| MARU | 28.00 | N/A | N/A |
| AllianzIM U.S. Equity Buffer15 UncMarETF | |||
| VMO | 9.55 | -0.01 | -0.10% |
| Invesco Municipal Opportunity Trust | |||
A.I.dvisor tells us that EAFG and GSK have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAFG and GSK's prices will move in lockstep.
| Ticker / NAME | Correlation To EAFG | 1D Price Change % | ||
|---|---|---|---|---|
| EAFG | 100% | N/A | ||
| GSK - EAFG | 19% Poorly correlated | +0.23% | ||
| ROG - EAFG | 19% Poorly correlated | +0.67% | ||
| AZN - EAFG | 12% Poorly correlated | +0.34% | ||
| GMAB - EAFG | 12% Poorly correlated | +0.21% | ||
| CFR - EAFG | 11% Poorly correlated | -0.25% | ||
More | ||||
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.